Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-9081
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population ; volume:3 ; number:1 ; day:25 ; month:7 ; year:2007 ; pages:1-12 ; date:12.2007
Behavioral and brain functions ; 3, Heft 1 (25.7.2007), 1-12, 12.2007
- Urheber
-
Vijayan, Neetha N.
Bhaskaran, Sujatha
Koshy, Linda V.
Natarajan, Chandrasekhar
Srinivas, Lekshmy
Nair, Chandrasekharan M.
Allencherry, Priya M.
Banerjee, Moinak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1744-9081-3-34
- URN
-
urn:nbn:de:101:1-2021082808274641036137
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vijayan, Neetha N.
- Bhaskaran, Sujatha
- Koshy, Linda V.
- Natarajan, Chandrasekhar
- Srinivas, Lekshmy
- Nair, Chandrasekharan M.
- Allencherry, Priya M.
- Banerjee, Moinak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations